Showing 1731-1740 of 23122 results for "".
A New Era of Hope in Non-Small Cell Lung Cancer Care
https://reachmd.com/programs/project-oncology/a-new-era-of-hope-in-non-small-cell-lung-cancer/49130/Outcomes in non-small cell lung cancer (NSCLC) are improving in ways many patients—and even some clinicians—may not fully appreciate. Join Dr. Geoffrey Oxnard as he explains how molecular testing, clinical trials, and novel targeted and immune therapies are transforming a once uniformly grim diagnosObesity and Asthma: Intersecting Pathways and Real-World Impacts
https://reachmd.com/programs/clinicians-roundtable/obesity-asthma-poor-disease-control/54181/Emerging evidence highlights a complex, bidirectional relationship between obesity and asthma, driven by shared genetics, epigenetic influences, environmental exposures, and metabolic dysfunction. Learn more with Dr. Anne Dixon, who’s a pulmonologist, professor, and the E. L. Amidon Chair of the DepBehind the Breakout: Acne as a Meaningful Side Effect of JAK Inhibitors for IBD
https://reachmd.com/programs/Audioabstracts/jak-inhibitors-acne-side-effect-ibd/49088/As JAK inhibitors become more widely used in treating inflammatory bowel disease (IBD), a new challenge is emerging: acne. That’s why Ryan Quigley spotlights the largest international cohort study to date examining JAK inhibitor-associated acne across more than 2,000 patients. Tune in to learn how fBalancing Benefits and Risks in Emerging Sickle Cell Therapies
https://reachmd.com/programs/project-oncology/balancing-benefits-and-risks-in-emerging-sickle-cell-therapies/36236/For decades, hydroxyurea has been the cornerstone therapy for sickle cell disease, but new disease-modifying therapies, curative strategies, and gene therapies are expanding options for patients. While these advancing approaches come with some risks, they can help offer symptom relief, reduce compliAdvocacy and Research
https://practicaldermatology.com/series/the-practical-dermatology-podcast/advocacy-and-research/36479/The latest news and updates, plus Harrison Nguyen, MD, MBA, MPH, FAAD, discusses addressing barriers to maximizing biologics for psoriasis, and Mark Lebwohl, MD, FAAD, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to talk about some of the latest research he has been involvUnderstanding Disparities in AD
https://practicaldermatology.com/series/updates-atopic-dermatitis/understanding-disparities-ad/29081/Dr. Raj Chovatiya, Clinical Associate Professor of Medicine at Rosalind Franklin University Chicago Medical School and Founder and Director of the Center for Medical Dermatology and Immunology Research, talks with Practical Dermatology about understanding disparities in atopic dermatitis and the socIdentifying Individualized Treatment Approaches for EOE Patients
https://reachmd.com/programs/gi-insights/identifying-individualized-treatment-approaches-for-eoe-patients/15394/There are several therapies for EOE, but not one algorithm fits every patient. Tune in to learn more about finding the right treatment for your patient.Assessing Non-Invasive Monitoring Techniques for Liver Fibrosis
https://reachmd.com/programs/gi-insights/assessing-non-invasive-monitoring-techniques-for-liver-fibrosis/13739/Let’s explore the non-invasive techniques we can use to assess liver fibrosis in our patients.Addressing Mental Health in Communities of Color
https://reachmd.com/programs/clinicians-roundtable/addressing-mental-health-in-communities-of-color/11780/Both COVID-19 and the protests against racism have had far-reaching impacts on black communities. Here’s how one mental health center has responded.Where Are We Now? New Findings About COVID-19 & How We’re Coping as a Society
https://reachmd.com/programs/public-health-call/where-are-we-now-new-findings-about-covid-19-how-were-coping-as-a-society/11565/It’s been a few months since COVID-19 first arrived in the US, so what have we learned?